Assessment of Anatomical Variations of Greater Palatine Foramen in a Sample of Egyptian Population (CBCT)
NCT ID: NCT04970186
Last Updated: 2021-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
173 participants
OBSERVATIONAL
2021-08-31
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prevalence and Anatomical Variations of Bifid Mandibular Canal in the Egyptian Population Using Cone Beam CT (CBCT)
NCT03804437
Effect of Different Voxel Sizes on Accuracy of CBCT Linear Measurements: Preclinical Study
NCT03229018
Assessment of Maxillary Sinus Septum and Its Prevalence in a Sample of Egyptian Population (CBCT)
NCT03605394
Measuring Soft Tissue Thickness by CBCT
NCT03932357
Assessment of the Anterior Loop of the IAN in a Sample of Egyptian Population Using CBCT
NCT04465617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. The CBCT Scans of this study will be obtained from the data base available at the department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University, Cairo, Egypt.
2. Being a retrospective study, CBCT scans of Egyptian patients who have already been subjected to CBCT examination as part of their dental diagnosis and/or treatment planning will be included according to the proposed eligibility criteria.
B)Participants:
Based on sample size calculation, a sample of 173 hemi-palate belonging to Egyptian individuals will be examined.
C) Variables:
* Details about variable
1. Diameter of GPF.
2. Location of GPF in relation to maxillary molars.
3. The distance between the GPF and the midline maxillary suture (MMS).
4. The distance between the GPF and the posterior border of the hard palate (PB).
5. Number of foramina.
6. Type of the hard palate and relation to GPF location:
* Palatal index
* Palatal height index
D)Data sources/ Measurements:
* Retrospective Data collection will be performed after the CBCT scans are pooled from the computer database.
* All the CBCT examinations will be scanned using CBCT machine (Planmeca promax 3D Mid).
* CBCT scans using different fields of view, with 0.4mm voxel size.
* The following parameters will be measured on these images in sagittal, coronal and axial planes:
1. Diameter of GPF.
2. Location of GPF in relation to maxillary molars as described by Ajmani (1994). Between the upper first and second molar - A In the midline of the upper second molar - B Between the upper second and third molar - C In the midline of the upper third molar - D Distal to the upper third molar - E
3. The distance between the GPF and the midline maxillary suture
4. The distance between the GPF and the posterior border of the hard palate (PB).
5. Number of GPF.
6. Type of the hard palate and relation to GPF location:
* Palatal index
* Palatal height index
* CBCT scans will be interpreted by two oral radiologists independently; blinded from demographic data of the patients and from the results of each other.
* One of them will evaluate the images twice with a period of two weeks between the two reading sessions.
* Then inter-observational and intra-observational reliability between the observers will be evaluated.
E) Addressing potential sources of bias:
No source of bias. CBCT scans will be coded and interpreted by two oral and maxillofacial radiologists independently blinded from demographic data of the patients and from the results of each other.
F) Study Size:
The aim of the study is to assess the diameter and location of the greater palatine foramen in a sample of Egyptian population. Based upon the results of Ikuta, Carla Renata Sanomiya, et al 2013, the diameter of greater palatine foramen= 3.1 mm (±0.47). Acceptable margin of error=7%, a total sample size of 173 hemi-palate will be sufficient. Sample size calculation was performed using Benchmark Six Sigma.
G) Sampling strategy: The sample will be collected by convenience sampling.
H) Quantitative variables:
Subgrouping will be created to assess the variables regarding the gender and side.
1. Diameter of GPF.
2. Location of GPF in relation to maxillary molars.
3. The distance between the GPF and the midline maxillary suture (MMS).
4. The distance between the GPF and the posterior border of the hard palate (PB).
5. Number of foramina.
6. Type of the hard palate and relation to GPF location:
* Palatal index
* Palatal height index
I) Statistical methods:
Data will be analyzed using IBM SPSS advanced statistics (Statistical Package for Social Sciences), version 21 (SPSS Inc., Chicago, IL). Numerical data will be described as mean and standard deviation or median and range. Categorical data will be described as numbers and percentages.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CBCT scans showing the floor of the maxillary sinus.
* No artifacts in the maxillary region, which will affect the quality of the image
Exclusion Criteria
* Patients with trauma, craniofacial surgery, orthognathic surgery and malignancies involving the maxillofacial region.
* Patients with cleft palate and other craniofacial anomalies.
* Dental implants in the alveolar region of premolars and molars due to artifacts.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Farid Medhat
principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORAD 7-1-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.